Compile Data Set for Download or QSAR
Report error Found 1264 of affinity data for UniProtKB/TrEMBL: P15428
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM50266122(CHEMBL4070789)
Affinity DataKi:  0.0600nMAssay Description:Inhibition of recombinant human C-terminal 6xHis-tagged 15-PGDH expressed in Escherichia coli using PGE2 as substrate after 15 mins in presence of NA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/14/2020
Entry Details Article
PubMed
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM50266252(CHEMBL4061483)
Affinity DataKi:  0.100nMAssay Description:Inhibition of 15-PGDH (unknown origin) using PGE2 as substrate preincubated for 12 hrs followed by dialysis for 12 hrs and subsequent addition of NAD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/14/2020
Entry Details Article
PubMed
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM50266252(CHEMBL4061483)
Affinity DataKi:  0.100nMAssay Description:Binding affinity to 15-PGDH (unknown origin) assessed as inhibition constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
PubMed
Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650862(US20240043440, Example 58B)
Affinity DataIC50: 0.130nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650874(US20240043440, Example 64A)
Affinity DataIC50: 0.360nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650800(US20240043440, Example 16 | US20240043440, Example...)
Affinity DataIC50: 0.400nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (5 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650868(US20240043440, Example 61A)
Affinity DataIC50: 0.440nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650855(US20240043440, Example 54A)
Affinity DataIC50: 0.450nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650883(US20240043440, Example 68A)
Affinity DataIC50: 0.480nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740678(US20250154162, Example 47)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740691(US20250154162, Example 60)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650865(US20240043440, Example 60A)
Affinity DataIC50: 0.5nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740656(US20250154162, Example 25)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740655(US20250154162, Example 24)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740654(US20250154162, Example 23)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740652(US20250154162, Example 21)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM556317(US11345702, Table 1.35 | US20230390274, Compound A...)
Affinity DataIC50: 0.5nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM740664(US20250154162, Example 33)
Affinity DataIC50: 0.5nMAssay Description:a. A solution of pH 7.5 containing 50 mM Tris-HCl, 0.01% Tween 20 was prepared with ultrapure water as a reaction buffer;b. A 10 mM mother liquor of ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650881(US20240043440, Example 67A)
Affinity DataIC50: 0.520nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650892(US20240043440, Example 74A)
Affinity DataIC50: 0.520nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650861(US20240043440, Example 58A)
Affinity DataIC50: 0.550nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650908(US20240043440, Example 86A)
Affinity DataIC50: 0.560nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650871(US20240043440, Example 62A)
Affinity DataIC50: 0.560nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650847(US20240043440, Example 50A)
Affinity DataIC50: 0.570nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650834(US20240043440, Example 43A)
Affinity DataIC50: 0.580nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650832(US20240043440, Example 42B)
Affinity DataIC50: 0.590nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650877(US20240043440, Example 65A)
Affinity DataIC50: 0.590nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM556286(US11345702, Table 1.4 | US20230390274, Compound A-...)
Affinity DataIC50: 0.600nMAssay Description:A hydroxyprostaglandin dehydrogenase inhibition screening biochemical assay can be performed to assess the synthesized inhibitors provided herein. Pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/5/2022
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650841(US20240043440, Example 47A)
Affinity DataIC50: 0.650nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650838(US20240043440, Example 46A)
Affinity DataIC50: 0.700nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650843(US20240043440, Example 48A)
Affinity DataIC50: 0.720nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650826(US20240043440, Example 39A)
Affinity DataIC50: 0.720nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650829(US20240043440, Example 41A)
Affinity DataIC50: 0.730nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650852(US20240043440, Example 52A)
Affinity DataIC50: 0.75nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650901(US20240043440, Example 81)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650796(US20240043440, Example 12 | US20240043440, Example...)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (5 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650823(US20240043440, Example 38A)
Affinity DataIC50: 0.760nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM347359(US9789116, SW033291 | US10301320, ID SW033291 | US...)
Affinity DataIC50: 0.760nMAssay Description:In vivo assays for 15-PGDH expression or 15-PGDH activity, e.g., ligands, agonists, antagonists, and their homologs and mimetics. The term modulator ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650911(US20240043440, Example 89A)
Affinity DataIC50: 0.770nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650854(US20240043440, Example 54)
Affinity DataIC50: 0.820nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650886(US20240043440, Example 70)
Affinity DataIC50: 0.880nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650863(US20240043440, Example 59)
Affinity DataIC50: 0.910nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650888(US20240043440, Example 72)
Affinity DataIC50: 0.930nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM347365(US9789116, SW206992 | US10301320, ID SW206992 | US...)
Affinity DataIC50: 0.970nMAssay Description:In vivo assays for 15-PGDH expression or 15-PGDH activity, e.g., ligands, agonists, antagonists, and their homologs and mimetics. The term modulator ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM347364(US9789116, SW206980 | US10301320, ID SW206980 | US...)
Affinity DataIC50: 0.970nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH in an in vitro assay. More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2019
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM347364(US9789116, SW206980 | US10301320, ID SW206980 | US...)
Affinity DataIC50: 0.970nMAssay Description:This Example provides data on a group of structural analogues of SW033291. Data provided includes level of induction of a 15-PGDH-luciferase fusion g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650887(US20240043440, Example 71)
Affinity DataIC50: 0.980nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650899(US20240043440, Example 79-A)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM650902(US20240043440, Example 82)
Affinity DataIC50: 1nMAssay Description:Each compound for inhibiting enzymatic activity of recombinant 15-PGDH (1 nM) in an in vitro assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2024
Entry Details
US Patent

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Ut Southwestern Medical Center

Curated by ChEMBL
LigandPNGBDBM50266223(CHEMBL4060121)
Affinity DataIC50: 1nMAssay Description:Inhibition of recombinant human C-terminal 6xHis-tagged 15-PGDH expressed in Escherichia coli using PGE2 as substrate after 15 mins in presence of NA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/14/2020
Entry Details Article
PubMed
Displayed 1 to 50 (of 1264 total ) | Next | Last >>
Jump to: